LIQUIDITY ALERT: Oscient Pharma Reports $11.37M Current Deficit
February 25, 2009
Oscient Pharmaceuticals Corporation reported a working capital deficit of US$11.37 million at Sept. 30, 2008, according to its Registration Statement filed on Form S-1 with the U.S. Securities and Exchange…
COMPANIES:
Oscient Pharmaceuticals Corp